相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
Devesh Tewari et al.
SEMINARS IN CANCER BIOLOGY (2022)
Identification and validation of L Antigen Family Member 3 as an immune-related biomarker associated with the progression of papillary thyroid cancer
Xubin Dong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects
Daniela Miricescu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Melatonin inhibiting the survival of human gastric cancer cells under ER stress involving autophagy and Ras-Raf-MAPK signalling
Yongye Huang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Up-regulation of L Antigen Family Member 3 Associates With Aggressive Progression of Breast Cancer
Xubin Dong et al.
FRONTIERS IN ONCOLOGY (2021)
PLEK2 promotes osteosarcoma tumorigenesis and metastasis by activating the PI3K/AKT signaling pathway
Yang Liu et al.
ONCOLOGY LETTERS (2021)
L Antigen Family Member 3 Serves as a Prognostic Biomarker for the Clinical Outcome and Immune Infiltration in Skin Cutaneous Melanoma
Jingjing Song et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Oxaliplatin and Gedatolisib (PKI-587) Co-Loaded Hollow Polydopamine Nano-Shells with Simultaneous Upstream and Downstream Action to Re-Sensitize Drugs-Resistant Hepatocellular Carcinoma to Chemotherapy
Yin-Ci Zhang et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2021)
LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells
Yongfang Ma et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Multimodal treatment of hepatocellular carcinoma
M. M. Kirstein et al.
INTERNIST (2020)
Upregulation of LAGE3 correlates with prognosis and immune infiltrates in colorectal cancer: A bioinformatic analysis
Xubin Dong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
LAGE3 correlates with tumorigenic immune infiltrates in the clear cell renal cell carcinoma microenvironment
Xubin Dong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Combinational Immunotherapy for Hepatocellular Carcinoma: Radiotherapy, Immune Checkpoint Blockade and Beyond
Yun Hua Lee et al.
FRONTIERS IN IMMUNOLOGY (2020)
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
Wafaa M. Rashed et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2020)
Integrative analyses of the RNA modification machinery reveal tissue- and cancer-specific signatures
Oguzhan Begik et al.
GENOME BIOLOGY (2020)
Targeting PI3K/AKT/mTOR-mediated autophagy for tumor therapy
Zhenru Xu et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)
What Comes First: Treatment of Viral Hepatitis or Liver Cancer?
Jordan J. Feld et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Identification of TP53RK-Binding Protein (TPRKB) Dependency in TP53-Deficient Cancers
Moloy T. Goswami et al.
MOLECULAR CANCER RESEARCH (2019)
The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells
Claudia Tanja Mierke
REPORTS ON PROGRESS IN PHYSICS (2019)
Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
Meran Keshawa Ediriweera et al.
SEMINARS IN CANCER BIOLOGY (2019)
Update on hepatocellular carcinoma: Pathologists' review
Tony El Jabbour et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Current Perspectives in Cancer Immunotherapy
Theodoulakis Christofi et al.
CANCERS (2019)
Defects in t6A tRNA modification due to GON7 and YRDC mutations lead to Galloway-Mowat syndrome
Christelle Arrondel et al.
NATURE COMMUNICATIONS (2019)
Goals and targets for personalized therapy for HCC
Thomas Couri et al.
HEPATOLOGY INTERNATIONAL (2019)
Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review
Zhu You et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma
Mohamed Bouattour et al.
HEPATOLOGY (2018)
Targeting ERK, an Achilles' Heel of the MAPK pathway, in cancer therapy
Feifei Liu et al.
ACTA PHARMACEUTICA SINICA B (2018)
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Luca Falzone et al.
FRONTIERS IN PHARMACOLOGY (2018)
Staging systems of hepatocellular carcinoma: A review
Sreeshma Tellapuri et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2018)
ASIC1a mediates the drug resistance of human hepatocellular carcinoma via the Ca2+/PI3-kinase/AKT signaling pathway
Yihao Zhang et al.
LABORATORY INVESTIGATION (2017)
Mortality assessment of patients with hepatocellular carcinoma according to underlying disease and treatment modalities
Pegah Golabi et al.
MEDICINE (2017)
Roles for RACK1 in cancer cell migration and invasion
Deirdre Duff et al.
CELLULAR SIGNALLING (2017)
分享论文
